183 related articles for article (PubMed ID: 33392275)
1. Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention.
Zhao X; Wang Y; Liu C; Zhou P; Sheng Z; Li J; Zhou J; Chen R; Chen Y; Zhao H; Yan H
Front Cardiovasc Med; 2020; 7():615254. PubMed ID: 33392275
[No Abstract] [Full Text] [Related]
2. Serum total bilirubin and long-term prognosis of patients with new-onset non-ST elevation myocardial infarction: a cohort study.
Yang Y; Wang J; Wai Si Ding AJGL; Xu Y; Jiang H; Ma K; Zhu T
BMC Cardiovasc Disord; 2022 Apr; 22(1):165. PubMed ID: 35413813
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
Gul M; Uyarel H; Ergelen M; Akgul O; Karaca G; Turen S; Ugur M; Ertürk M; Kul S; Surgit O; Bozbay M; Uslu N
Am J Cardiol; 2013 Jan; 111(2):166-71. PubMed ID: 23102877
[TBL] [Abstract][Full Text] [Related]
4. Initial Total Bilirubin and Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents.
Chung SR; Yang TH; Shin HC; Jin HY; Seo JS; Jang JS; Kim DK; Kim DS; Seo GW; Song PS; Kim DK; Kim KH; Seol SH; Kim DI; Cho YK; Yoon HJ; Nam CW; Hur SH; Kim U; Park JS; Kim YJ
Circ J; 2016 May; 80(6):1437-44. PubMed ID: 27151334
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
6. Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study.
Tuxun M; Zhao Q; Xiang Y; Liu F; Shan CF; Zhou XR; Song N; Waisiding A; Zhang XH; Aihemaiti G; Yang YN; Li XM
BMJ Open; 2020 Feb; 10(2):e031227. PubMed ID: 32075822
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
[No Abstract] [Full Text] [Related]
8. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
9. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
Farag M; Spinthakis N; Gue YX; Srinivasan M; Sullivan K; Wellsted D; Gorog DA
Eur Heart J; 2019 Jan; 40(3):295-305. PubMed ID: 30380032
[TBL] [Abstract][Full Text] [Related]
10. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
11. Combined value of red blood cell distribution width and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI.
Chang XW; Zhang SY; Wang H; Zhang MM; Zheng WF; Ma HF; Gu YF; Wei JH; Qiu CG
Oncotarget; 2018 Mar; 9(17):13971-13980. PubMed ID: 29568409
[TBL] [Abstract][Full Text] [Related]
12. [Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction].
Shen C; Wang LF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):49-55. PubMed ID: 30669810
[No Abstract] [Full Text] [Related]
13. Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India-Kerala Primary Percutaneous Coronary Intervention Registry.
Jabir A; Mathew A; Zheng Y; Westerhout C; Viswanathan S; Sebastian P; Kumar P; Bangalore S; Bainey KR; Welsh R
J Am Heart Assoc; 2020 Jun; 9(12):e014968. PubMed ID: 32476563
[TBL] [Abstract][Full Text] [Related]
14. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI.
Celik T; Kaya MG; Akpek M; Yarlioglues M; Sarli B; Topsakal R; Gibson CM
Angiology; 2014 Mar; 65(3):198-204. PubMed ID: 23378197
[TBL] [Abstract][Full Text] [Related]
15. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
[TBL] [Abstract][Full Text] [Related]
16. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
17. Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.
Tan Y; Zhou J; Yang S; Li J; Zhao H; Song L; Yan H
Front Pharmacol; 2021; 12():632075. PubMed ID: 34650427
[No Abstract] [Full Text] [Related]
18. Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes.
Cho HO; Nam CW; Lee HM; Shin HW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Hur SH; Kim YN; Kim KB
Int J Cardiol; 2014 Jan; 170(3):376-80. PubMed ID: 24290071
[TBL] [Abstract][Full Text] [Related]
19. Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Liang S; Li H; Shen X; Liu R
J Clin Lab Anal; 2019 Jun; 33(5):e22864. PubMed ID: 30779470
[TBL] [Abstract][Full Text] [Related]
20. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
